Advanced CIDP 1

Study Information

Status: Active, Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

San Francisco

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Principal Investigator

Jonathan Katz, M.D.

Co-Investigator(s)

Liberty Jenkins, MD

Related Studies

GXCA

Gene Expression of Cerebral Aneurysms // [EMC]

Investigator: Lawrence Dickinson, M.D

Genetics and Comorbidity of Migraine

Identify common genetic variants for migraine to determine whether there are single nucleotide polymorphisms associated with migraine.

Investigator: Alice R. Pressman, Ph.D., M.S.

Mindfulness and Migraine: A Randomized Controlled Trial

Conduct a randomized controlled feasibility trial of mindfulness-based stress reduction for patients with moderate-to-severe migraine headache.

Investigators: Sylvia Sudat, PhD, Alice R. Pressman, Ph.D., M.S.

Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes

Use EHRs and survey data to characterize migraineurs at Sutter Health by demographic, comorbidity, symptom, and care gap profiles, to see if tx needs are met.